Navigating Clinical Trials in Japan: From Regulatory Strategy to Operational Success

Published on: Mar 28, 2025

In today's dynamic global pharmaceutical landscape, understanding Japan's regulatory environment is crucial. This virtual session explores strategies for drug development in Japan, including its role in global Phase III studies and PMDA interactions. We examine unique aspects of Japanese clinical trials, addressing challenges and solutions. Through case studies participants will learn to navigate Japan's regulatory landscape and optimize clinical development in this key market.
This webinar covers:

  • Navigating Japan's Regulatory Landscape
  • Achieving Operational Excellence in Japanese Clinical Trials
  • Featured Case Studies
     

Watch now

Return to Insights Center

Related Insights

Blog

Regulatory outsourcing: Applying change management best practices for smoother transitions

Jul 24, 2025

Whitepaper

Scientific Validity Reports: a mandatory requirement for In Vitro Diagnostic Regulation (IVDR)

Sep 19, 2023

Whitepaper

The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations

Mar 9, 2023

Playbook

Mitigating risk, protecting potential: Practical strategies that position cell and gene therapy development for success

Mar 28, 2023

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Webinar

Assessing appropriate use of ECAs in clinical trials

May 28, 2023

Blog

Celebrating 40 Years of Rare Disease Progress: WODC Highlights

Jun 6, 2023

Blog

Population variability: important considerations in vaccine development

Jun 14, 2023

Whitepaper

How to prepare for Policy 0070: Challenges and opportunities for clinical data publication in the EU

Jun 28, 2023

Article

The technologies that are reshaping biotherapeutics manufacturing, an EU perspective

Jul 6, 2023

Blog

Ensuring future success in a new market by delivering a robust safety database solution

Aug 4, 2023

Related Insights

Blog

Regulatory outsourcing: Applying change management best practices for smoother transitions

Jul 24, 2025

Whitepaper

Scientific Validity Reports: a mandatory requirement for In Vitro Diagnostic Regulation (IVDR)

Sep 19, 2023

Whitepaper

The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations

Mar 9, 2023

Playbook

Mitigating risk, protecting potential: Practical strategies that position cell and gene therapy development for success

Mar 28, 2023

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Show more